Entity
Description
  • Value proposition

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

    Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation

  • Original language

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

  • TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All

    TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.

  • https://treefrog.fr/
Catalyst interactions
Catalyst TypeTweets Articles
Gouvernement Gouvernement
Other

22 May 2024


Institut du Cerveau – Paris Brain Institute
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Institut du Cerveau – Paris Brain Institute
Startup accelerator & VC, Biotechnology Research
Other

8 Mar 2023


Inria
Inria
Research, Research Services
Inria
Research, Research Services
Other

8 Mar 2023


EY Pythagoras
EY Pythagoras
IT Services and IT Consulting
EY Pythagoras
IT Services and IT Consulting
Other

25 Nov 2021


French Tech Bordeaux
French Tech Bordeaux
French Tech, IT Services and IT Consulting
French Tech Bordeaux
French Tech, IT Services and IT Consulting
Not capitalistic
Not partnership
Event

7 Dec 2021

17 Jul 2024



Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Event

15 Nov 2021


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Not capitalistic
Not partnership
Event

13 Sep 2021

26 Apr 2024



EU-Startups
EU-Startups
Media, Software Development
EU-Startups
Media, Software Development
Capitalistic
Not partnership
Not event

13 Sep 2021


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

18 Jan 2022


Pierre Fabre Laboratories
Pierre Fabre Laboratories
Pharmaceutical, Pharmaceutical Manufacturing
Pierre Fabre Laboratories
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

9 Mar 2020


Social network dynamics
Similar entities
BETA
Loading...
Loading...